SCHEMBL7969869

SCHEMBL7969869

COc1c(C(C)(C)C)cc(COc2ccc(C=O)cc2)cc1C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.49
TUBB1 Q9H4B7 2/20 0.48
NPC1 O15118 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
TNFRSF1A P19438 2/20 0.46
PDCD1 Q15116 1/20 0.45
CD274 Q9NZQ7 1/20 0.45
ALDH1A1 P00352 4/20 0.45
CYP2A6 P11509 1/20 0.45
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27610920 0.79 ALDH1A1 (0.58) RAB9ATUBB1NPC1TDP1ALDH1A1
SCHEMBL8558338 0.78 DHFR (0.40) TUBB1TDP1TNFRSF1AALDH1A1TUBB4A
SCHEMBL864643 0.76 RAB9A (0.69) RAB9ANPC1TDP1ALDH1A1CYP2A6
SCHEMBL9129690 0.76 RAB9A (0.69) RAB9ANPC1TDP1ALDH1A1CYP2A6
SCHEMBL7958272 0.75 MMP13 (0.64) HPGDMEN1KMT2A
SCHEMBL7958269 0.75 MMP13 (0.64) HPGDMEN1KMT2A
SCHEMBL5365834 0.75 TNFRSF1A (0.46) TDP1TNFRSF1AALDH1A1CYP2A6HPGD
SCHEMBL3997051 0.75 APP (0.64) RAB9ANPC1TDP1ALDH1A1MAPT
SCHEMBL348599 0.74 RAB9A (0.58) RAB9ANPC1TDP1ALDH1A1CYP2A6
SCHEMBL23223734 0.73 RAB9A (0.69) RAB9ANPC1TDP1ALDH1A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed